[{"Assets_0_Q3_USD":"10322000000.0","CIK":"1596783","CommonStockSharesIssued_0_Q3_shares":"179147001.0","CommonStockSharesOutstanding_0_Q3_shares":"179147001.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.78","EarningsPerShareBasic_3_Q3_USD":"1.81","EarningsPerShareDiluted_1_Q3_USD":"0.78","EarningsPerShareDiluted_3_Q3_USD":"1.79","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"17076283108.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"370000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"141000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"316000000.0","NetIncomeLoss_1_Q3_USD":"141000000.0","NetIncomeLoss_3_Q3_USD":"331000000.0","OfficialName":"Catalent Inc. Common Stock","ProfitLoss_3_Q3_USD":"331000000.0","RevenuesConverted_1_Q3_USD":"1273000000.0","RevenuesConverted_3_Q3_USD":"3515000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"4632000000.0","StockholdersEquity_0_Q3_USD":"4632000000.0","Ticker":"CTLT","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"181000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"177000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"180000000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"176000000.0","filed":"20220503","footnote":null,"form":"10-Q","fp":"Q3","fy":"2022.0","name":"CATALENT, INC.","period":"20220331","qtrs":"0","uom":"USD"}]